May 20, 2026 08:45
May 20, 2026 09:30
Alex Gray
International Moderator
Kevin Bürchler
SIP Medical Family Office
May 20, 2026 09:40
Dr. Erik Holy
Swiss CVC
Cardiovascular disease remains the dominant driver of early mortality worldwide. This session focuses on evidence-based prevention strategies, from advanced risk stratification and lipid management to lifestyle, digital monitoring, and system-level interventions. It highlights where prevention delivers the greatest longevity impact and how to translate guidelines into measurable, long-term outcomes.
May 20, 2026 10:00
Shane Bakker
Health Corp
Harry Büsser
Author
Dr. Hubert Trübel
The Knowledge House GmbH
This session critically examines emerging longevity interventions, including NMN, GLP-1s, collagen, photobiomodulation, and more. It assesses biological rationale, clinical evidence, regulatory status, real-world outcomes, highlighting where promise is justified, where risks remain, and how clinicians, investors, and patients should interpret rapidly evolving claims.
May 20, 2026 10:30
May 20, 2026 10:45
Dr. Christian H Kälin
SIP Medical Family Office
This session cuts through longevity hype and emphasized why it is important to focus on scientifically validated, clinically relevant, and practically actionable care only. It explores how to distinguish robust evidence from speculation, marketing, and experimental care, and debates why more common sense is required in the longevity conversation: Enjoying life, friendship, and balance to achieve a high- quality lifestyle.
May 20, 2026 11:15Oral health is a powerful yet often overlooked driver of longevity. Conditions such as gum disease are linked to systemic inflammation, cardiovascular risk, and cognitive decline. This session explores how maintaining a healthy mouth can support whole-body health and extend healthspan.
May 20, 2026 11:45
Léa Wagenaar
SIP Medical Family Office
This session critically evaluates the most popular dietary supplements in longevity and preventive medicine. It reviews mechanistic claims, clinical evidence, and placebo effects, distinguishing meaningful interventions from marketing-driven products. Participants gain a practical framework to assess supplement efficacy, safety, and relevance within evidence-based longevity and prevention strategies.
May 20, 2026 12:15Join us for lunch and take the opportunity to network with our partners and fellow attendees. A special book signing will also be available, offering the chance to meet the authors and have your copy personally signed.
Featuring:
May 20, 2026 13:00
Kevin Bürchler
SIP Medical Family Office
Dr. Aaron Dehghan
Nexus Longevity
Most people will face complex medical decisions at some point in their lives. This session uses real patient cases to illustrate how important it is to know how to navigate the healthcare system when becoming a patient. It offers practical lessons on preparation, advocacy, second opinions, and decision-making to help patients reduce avoidable harm and navigate care more effectively.
May 20, 2026 13:30This session explores how employers can move beyond symbolic wellness perks to deliver measurable health and productivity outcomes. It examines preventive programs, personalized health services, data-driven incentives, and alignment with corporate strategy, showing how well-designed health benefits reduce risk, improve engagement, and create long-term value for employees and organizations.
May 20, 2026 13:50
Jacopo Zamboni
Henley & Partners Switzerland AG
Healthcare accessibility and quality are among the top 5 drivers of HNW migration. This session analyses global mobility trends, preferred jurisdictions, and policy implications—showing how health considerations increasingly shape residency decisions, wealth structuring, and long-term family strategy.
May 20, 2026 14:10
Dr. Dominik Thor
Geneva College of Longevity Science
Preventive medicine has the potential to improve population health while reducing long-term costs. This session examines how insurers and public healthcare systems can scale prevention through data, incentives, and care redesign. It discusses access, equity, economic trade-offs, and implementation barriers shaping the future of prevention at system level.
May 20, 2026 14:30Longevity has emerged as a rapidly expanding investment theme, attracting capital across biotech, diagnostics, digital health, and services. This session reviews market size assumptions, deal flow, valuation dynamics, and recent transactions, separating durable opportunities from hype and highlighting where capital can generate both financial returns and real health impact.
May 20, 2026 15:00
May 20, 2026 15:15
Shane Bakker
Health Corp
Elite athletes require health management strategies that widely differ from the public. This session examines longevity for athletes, medical insurance challenges, and the financial safeguards for career-ending events. Speakers explore how structured healthcare access, risk transfer, and long-term financial planning can preserve both physical capital and post-career wealth.
May 20, 2026 15:30
Nathan Ikon Crumpton
Olympian
Dr. Aaron Dehghan
Nexus Longevity
Longevity isn’t a problem with a single solution—it’s an optimization challenge shaped by tradeoffs. In complex systems, you can’t maximize everything at once, and human health is no exception. Rather than chasing a cure for mortality, this session explores how to make deliberate choices between competing priorities like lifespan, quality of life, risk, and enjoyment.
May 20, 2026 16:00
Dr. Athanasios Papatsoris
National & Kapodistrian University of Athens
Most people will encounter complex medical decisions at some stage in their lives. Drawing on real patient experiences, this session explores the importance of navigating the healthcare system effectively once you step into the role of a patient. Framed through a reflective, human-centred lens, it weaves in elements of eurology—acknowledging the lived experience, values, and dignity of individuals—while offering practical guidance on preparation, self-advocacy, seeking second opinions, and making informed choices. The aim is to reduce avoidable harm and support better, more compassionate care outcomes.
May 20, 2026 16:30
Oliver Neubert
NEOVIVA
Addiction represents a significant but often underestimated risk factor within wealthy families, influencing judgment, governance, and capital allocation. Beyond its human cost, it can lead to impaired decision-making, erosion of assets, and intergenerational consequences. This session examines addiction through a strategic lens, emphasizing prevention, early detection, and the importance of structured support systems.
May 20, 2026 17:00Cognitive decline is one of the greatest fears of aging, yet many risk factors are modifiable. This session explores evidence-based strategies for cognitive longevity, including cardiovascular health, sleep, nutrition, mental stimulation, and emerging diagnostics, offering practical insights on how to preserve brain function and resilience well into later life.
May 20, 2026 17:30
Vincent Corver
Swiss Sonic
Music is more than art—it is a powerful modulator of human biology. Research shows that music can reduce stress, enhance cognitive resilience, and support emotional wellbeing, all key drivers of healthy aging. This session explores the science of sound alongside a live piano performance, illustrating how music can contribute to a longer, healthier life.
May 20, 2026 17:45
Alex Gray
International Moderator
Followed by Networking Drinks Reception